Ying Huang

5PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial.

|Dec 15, 2025
Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study.

Shui-Qing He, Ying Huang, Ze-Yu Zhao

|Apr 03, 2025
Magnetic Resonance Imaging and [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Guided Therapy Improves Survival in Upper Aerodigestive Tract NK/T-Cell Lymphoma, Nasal Type: A Prospective Cohort Study.

Quanguang Ren, Yue Cui, He Huang

|Feb 28, 2024
Correction: Predictive progression outcomes and risk stratification in patients with recurrent or metastatic nasopharyngeal carcinoma who received first‑line immunochemotherapy.

Danjie He, Yudong Zhang, Shuiqing He

|Dec 09, 2023
Predictive progression outcomes and risk stratification in patients with recurrent or metastatic nasopharyngeal carcinoma who received first-line immunochemotherapy.

Danjie He, Yudong Zhang, Shuiqing He

Pageof 1

Frequent Collaborators

2 joint publications

Qingqing Cai

1 joint publications

Quanguang Ren

1 joint publications

Shui-Qing He

1 joint publications

Ze-Yu Zhao